AURA
Aura Biosciences Inc

207
Mkt Cap
$342.92M
Volume
84,815.00
52W High
$9.53
52W Low
$4.35
PE Ratio
-2.80
AURA Fundamentals
Price
$5.42
Prev Close
$5.40
Open
$5.54
50D MA
$5.94
Beta
1.31
Avg. Volume
287,230.91
EPS (Annual)
-$1.75
P/B
2.17
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Insider Selling: Aura Biosciences (NASDAQ:AURA) Insider Sells 17,109 Shares of Stock
Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Janet Jill Hopkins sold 17,109 shares of the stock in a transaction that occurred on Monday, November 17th. The shares were sold at an...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Aura Biosciences (NASDAQ:AURA) Releases Earnings Results
Aura Biosciences (NASDAQ:AURA - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.40) EPS for the quarter, beating analysts' consensus estimates of ($0.46) by $0.06...
MarketBeat·6d ago
News Placeholder
Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease
Aura Biosciences released early Phase 1 trial data on bel-sar for non-muscle-invasive bladder cancer, showing promising clinical activity and a favorable safety profile. read more...
Benzinga·1y ago
News Placeholder
Aura Biosciences Inc: A Buy Rating on Strong Pipeline and Financial Health
Andrew Berens, an analyst from Leerink Partners, maintained the Buy rating on Aura Biosciences Inc (AURA Research Report). The associated price t...
TipRanks Financial Blog·2y ago
News Placeholder
Aura Biosciences (AURA, $7.7) Aroon Indicator entered a Downtrend on March 27, 2024.
For the last three days, A.I.dvisor has detected that AURA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Tickeron - Stocks·2y ago
News Placeholder
Recap: Aura Biosciences Q4 Earnings
read more...
Benzinga·2y ago
News Placeholder
Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors to preserve the function of the afflicted organ with cancer...
Business Wire·2y ago
News Placeholder
Contrasting Aura Biosciences (NASDAQ:AURA) and Atara Biotherapeutics (NASDAQ:ATRA)
Aura Biosciences (NASDAQ:AURA Get Free Report) and Atara Biotherapeutics (NASDAQ:ATRA Get Free Report) are both small-cap medical companies, but which is the better investment? We...
Zolmax·2y ago
News Placeholder
Aura Biosciences to Participate in Upcoming Investor Conferences
Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced...
Business Wire·2y ago
News Placeholder
Aura Biosciences (AURA, $8) Aroon Indicator entered a Downtrend on February 13, 2024.
For the last three days, A.I.dvisor has detected that AURA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Tickeron - Stocks·2y ago

Latest AURA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.